期刊文献+

血液病毒核酸检测与酶联免疫检测比较研究 被引量:11

Comparison of ELISA and NAT testing of blood
原文传递
导出
摘要 目的对酶联免疫检测血样做NAT检测,分析酶联免疫筛查献血者血样误检的原因。方法对献血者血样进行HBsAg、HCVAb和HIVAb二次ELISA筛查,阴性和阳性血样分别做NAT检测,对HBsAg阴性、HBV DNA阳性献血者做HBV两对半免疫检测和罗氏病毒含量定量测定。结果对二次ELISA筛查及转氨酶和螺旋体检测合格的29 852份血样进行NAT检测,其中15份HBV DNA阳性,漏检率为0.50‰,未发现HCV和HIV RNA阳性。15份HBV DNA阳性献血者乙肝两对半免疫检测,HBsAg均为阴性,7份HBsAb阳性,1份HBeAg阳性,7份HBeAb为阳性,11份HBcAb为阳性。其中1份HBsAg阴性DNA阳性血样HBV罗氏定量为2 520IU/ml,血液存在严重传染可能。对151份二次ELISA阳性血样进行NAT检测,有83份阴性,ELISA的灵敏度为81.93%,特异度为99.72%。结论二次酶联免疫检测法的灵敏度较低,增加抗原、抗体检测和NAT检测可减少漏检。 Objective To determine how many blood samples may be overlooked by ELISA testing.Methods First,double ELISA testing was performed on donor blood samples and NAT testing was performed on samples that were negative and positive for HBsAg,anti-HCV,and anti-HIV according to ELISA.Second,the donors' samples were pooled with a HAMILTON STAR sampling processor and nucleic acid was extracted with the EZbead System-32.HBV DNA,HCV RNA,and HIV RNA were amplified and detected with an ABI quantitative Fluorescence PCR instrument.Third,donor samples that were negative for HBsAg but positive for HBV DNA were subjected to double ELISA(HBsAg HBsAb HBeAg HBeAb HBcAb) and a Roche Quantitative Assay.At the same time,sensitivity and specificity were preliminarily determined.Results Of 30 315 donor blood samples,29 852 samples tested with ELISA and negative for ALT and syphilis were tested with NAT;15 samples were positive for HBV DNA.No HCV RNA and HIV RNA were detected.None of the 15 donor samples were positive for HBsAg,7 were positive for HBsAb,1 was positive for HBeAg,7 were positive for HBeAb,and 11 were positive for HBcAb.One result tested positive with 2 520 IU/ml according to the Roche Quantitative Assay.Of 151 donor samples that tested positive according to ELISA,83 tested negative according to NAT testing.Conclusion The results showed that screening with ELISA missed 0.50‰ of HBV with HBsAg.Double ELISA testing had a sensitivity of 81.93% and specificity of 99.72%.
出处 《中国病原生物学杂志》 CSCD 2011年第10期732-735,共4页 Journal of Pathogen Biology
关键词 酶联免疫技术 病毒核酸扩增技术 HBV、HCV、HIV定量检测 HBV感染 ELESA nucleic acid amplification test(NAT) HBV HCV HIV quantitative test HBV infection
作者简介 赵俊鹏(1985-),男,在读硕士研究生,从事病原生物学研究。Email:345103770@qq.com 【通讯作者】田喜凤,Email:tstianxifeng@163.com
  • 相关文献

参考文献20

二级参考文献180

共引文献301

同被引文献121

  • 1庄辉.乙型肝炎流行病学研究进展[J].中国医学前沿杂志(电子版),2009,1(2):18-24. 被引量:91
  • 2刘德春,孙波,徐群,李京,吕红娟,乔文本.核酸检测技术与酶联免疫检测技术在血液筛检中的初步应用比较[J].中国输血杂志,2007,20(1):43-45. 被引量:40
  • 3王良华,邬旭群,鲍自谦,陈云龙,叶贤林,尚桂芳,杨立新.不同ELISA试剂HBsAg初复检结果的比较[J].中国输血杂志,2007,20(2):124-125. 被引量:13
  • 4Rosenbaum E,Carducci MA.Pharmacotherapy of hormone refractory prostate cancer:new developments and challenges.Expert Opin Pharmacother,2003,4:875-887.
  • 5Pirani JF.The effects of phytotherapeutic agents on prostate cancer:an overview of recent clinical trails of PC SPES.Urology,2001,58:36-38.
  • 6Leutjens KB,Eekelen CC,Korput HA.Two androgen response regions cooperate insteroid hormone regulated activity of the prostatespecific antigen promoter.J Biol Chem,1996,271:6379-6388.
  • 7Yang E,Korsmeyer SJ.Molecular than atopsis:a discourse on the Bcl-2 family and cell death.Blood,1996,88:386-401.
  • 8Furuya Y,Krajewski S,Epstein JI,et al.Expression of bcl-2 and progression of human and rodent prostatic cancers.Clin Cancer Rea,1996,2:389-398.
  • 9Raffo A J,Perlman H,Chen MW,et al.Overexpression of bcl-2 protects prostate cancer cella from apoptosis in vitro and confers resistance to androgen depletion in vivo.Cancer Rea,1995,55:4438-4445.
  • 10Berchem GJ,Bosseler M,Sugars LY,et al.Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells.Cancer Res,1995,55:735-738.

引证文献11

二级引证文献63

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部